TORY FISHER: Open Payments
NPI 1740790500 · SPRING HILL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 45 payments from 7 companies in 2025. Trend: 2023 $466 · 2024 $477 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| ABBVIE INC. | 21 | $204 |
| Lilly USA, LLC | 7 | $146 |
| Axsome Therapeutics, Inc. | 5 | $92 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Novo Nordisk Inc | 4 | $62 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: FARXIGA, MOUNJARO, VRAYLAR, Auvelity, Qelbree, QULIPTA, Ozempic, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
